In silico drug repositioning: from large-scale transcriptome data to therapeutics
Kwon Ok-Seon, 김완규, 차혁진, Lee Hae-Seung,
소속 상세정보
( Kwon Ok-Seon )
Seoul National University College of Pharmacy
김완규 ( Kim Wan-Kyu )
Ewha Womans University Department of Life Sciences
차혁진 ( Cha Hyuk-Jin )
Seoul National University College of Pharmacy
( Lee Hae-Seung )
Ewha Womans University Department of Life Sciences
Abstract
Drug repositioning is an attractive alternative to conventional drug development when new beneficial effects of old drugs are clinically validated because pharmacokinetic and safety profiles are generally already available. Since ~?30% of drugs newly approved by the US food and drug administration (FDA) are developed through drug repositioning, identifying novel usage for existing drugs is an emerging strategy for developing disease treatments. With advances in next-generation sequencing technologies, available transcriptome data related to diseases have expanded rapidly. Harnessing these resources enables a better understanding of disease mechanisms and drug mode of action (MOA), and moves toward personalized pharmacotherapy. In this review, we briefly outline publicly available large-scale transcriptome databases and tools for drug repositioning. We also highlight recent approaches leading to the discovery of novel drug targets, drug response biomarkers, drug indications, and drug MOA.
키워드
Drug repositioning; In silico drug repositioning; Transcriptome; Pharmacogenomics; Big data
원문 및 링크아웃 정보
등재저널 정보